Frontal cerebral blood flow is impaired in patients with heart transplantation

Transplant International

Volumn 15, Issue 9-10, 2002, Pages 459-462

  Burra, Patrizia ^a   Senzolo, Marco ^a   Pizzolato, Gilberto ^a   Tursi, Vincenzo ^b   Livi, Ugolino ^b   Chierichetti, Franca ^a   Dam, Mauro ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

99mTc hexamethyl propylene amineoxime; Cerebral blood flow; Cyclosporine; Heart transplantation; Liver transplantation; Single photon emission computed tomography

Indexed keywords

CYCLOSPORIN; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN PERFUSION; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; COGNITION; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART TRANSPLANTATION; HUMAN; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; CYCLOSPORINE; FEMALE; FRONTAL LOBE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036944039     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2002.tb00200.x     Document Type: Article

References (24)

1. Abildstrom H, Rasmussen LS, Rentlow P, Hanning CD, Rasmussen H, Kristensen PA, Moller TJ (2000) Cognitive dysfunction 1-2 years after noncardiac surgery in the elderly. Acta Anaesthesiol Scand 10:1246-1251
2. Bechstein WO (2000) Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 13:313-326
3. Bornstein RA, Starling RC, Myerowitz P, Haas GJ (1995) Neuropsychological function in patients with end-stage heart failure before and after cardiac transplantation. Acta Neurol Scand 91:260-265
4. 99mTc-hexamethyl-propyleneamineoxide in cirrhotic patients before and after liver transplantation. Transplant Proc 26:3677-3678
5. 99mTc-HM-PAO single-photon emission computed tomography: effect of liver transplantation. J Hepatol 29:78-84
6. Grimm M, Yeganehfar W, Laufer G, Madl C, Kramer L, Eisenhuber E, Simon P, Kupilik N, Schreiner W, Pacher R, Bunzel B, Wolner E, Grimm G (1996) Cyclosporine may affect improvement of cognitive brain function after successful cardiac transplantation. Circulation 94:1339-1345
7. Hockerstedt K, Kajaste S, Muuronen A, Raininko R, Seppalainen AM, Hillbom M (1992) Encephalopathy and neuropathy in end-stage liver disease before and after liver transplantation. J Hepatol 16:31-37
8. Jain A, Brody D, Hamad I, Rishi N, Kanal E, Fung J (2000) Conversion to Neoral for neurotoxicity after primary adult liver transplantation under tacrolimus. Transplantation 69:172-176
9. Leenders KL, Perani D, Lammertsma AA, Heather JD, Buckingham P, Healy M J, Gibbs JM, Wise RJ, Hatazawa J, Herold S (1990) Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain 113:27-47
10. Lockwood AH, Yap EWH, Rhoades HM, Wong WH (1991) Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy. J Cereb Blood Flow Metab 11:331-336
11. Lockwood AH, Murphy BW, Donnelly KZ, Mahal TC, Perini S (1993) Positron-emission tomography localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. Hepatology 18:1061-1068
12. Lockwood AH, Weissenborn K, Butterworth RF (1997) An image of the brain in patients with liver disease. Curr Opin Neurol 10:525-533
13. Montero CG, Martinez AJ (1986) Neuropathology of heart transplantation: 23 cases. Neurology 36:1149-1154
14. Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH, Mark DB, Reves JG, Brumenthal JA (2001) Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 344:395-402
15. O'Carroll RE, Hayes PC, Ebmeier KP, Dougall N, Murray C, Best JJ, Bouchier IA, Goodwin GM (1991) Regional cerebral blood flow and cognitive function in patients with chronic liver disease. Lancet 337:1250-1253
16. Parvex P, Pinsk M, Bell LE, O'Gorman AM, Patenaude YG, Gupta IR (2001) Reversible encephalopathy associated with tacrolimus in pediatric renal transplants. Pediatr Nephrol 16:537-542
17. Rodriguez G, Testa R, Celle G, Gris A, Marenco S, Nobili F, Novellone G, Rosadini G (1997) Reduction of cerebral blood flow in subclinical hepatic encephalopathy and its correlation with plasma-free tryptophan. J Cereb Blood Flow Metab 7:768-772
18. Roman DD, Kubo SH, Ormaza S, Francis GS, Bank AJ, Shumway SJ (1997) Memory improvement following cardiac transplantation. J Clin Exp 19:692-697
19. Sakamoto Y, Makuuchi M, Harihara Y, Imamura H, Sato H (2000) Correlation between neurotoxic events and intracerebral concentration of tacrolimus in rats. Biol Pharm Bull 23:1008-1010
20. Schall RR, Petrucci RJ, Brozena SC, Cavarocchi NC, Jessup M (1989) Cognitive function in patients with symptomatic dilated cardiomyopathy before and after cardiac transplantation. J Am Coll Cardiol 14:1666-1672
21. Schober R, Herman MN (1973) Neuropathology in cardiac transplantation: survey of 31 cases. Lancet 1:962-994
22. Serkova N, Brand A, Christians U, Leibfritz D (1996) Evaluation of the effects of immunosuppressants on neuronal and glial cells in vitro by multinuclear magnetic resonance spectroscopy. Biochem Biophys Acta 8:93-104
23. Sorenson JA (1974) Qualitative measurement of radioactivity in vivo by whole body counting. Academic Press, New York
24. Tun SZ, Sen S, Eisen H, Kendler A, Greenstein JI (1988) Frontal lobe atrophy in orthotopic heart transplant patients. Neurology 50:A49